DSCS, a New Cell Line Developed in vitro From Human Stem Cells of the Apical Papilla.

Diana Sanz-SerranoCristina Sánchez-de-DiegoMontse MercadeFrancesc Ventura

Published in: International endodontic journal (2022)

The new cell line derived from human SCAPs has multipotency, retains its morphology and expression of mesenchymal surface markers, and shows higher proliferative capacity even at late passages (P45). DSCS cells can be used for in vitro study of root development and to achieve better understanding of the regenerative mechanisms.

Keyphrases

stem cells
endothelial cells
induced pluripotent stem cells
induced apoptosis
pluripotent stem cells
poor prognosis
cell therapy
mesenchymal stem cells
bone marrow
cell cycle arrest
cell death